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CASE REPORT Open Access
Bickerstaff’s brainstem encephalitis, Miller Fisher
syndrome and Guillain-Barré syndrome overlap in
an asthma patient with negative anti-ganglioside
antibodies
Chongyu Han1, Yuan Wang2, Jianping Jia2, Xunming Ji2, Vance Fredrickson3, Yuchuan Ding3, Wei Sun2, Jia Xu1
and Yong-Xin Sun2*
Abstract
Background: Bickerstaff’s brainstem encephalitis (BBE), together with Miller Fisher syndrome (MFS) and Guillain-Barré
syndrome (GBS) were considered to form a continuous clinical spectrum. An anti-GQ1b antibody syndrome has been
proposed to underlie the common pathophysiology for the three disorders; however, other studies have found a
positive anti-GM1 instead of anti-GQ1b antibody.
Case presentation: Here we report a 20-year-old male patient with overlapping BBE, MFS and GBS. The patient had a
positive family history of bronchial asthma and had suffered from the condition for over 15 years. He developed BBE
symptoms nine days after an asthma exacerbation. During the course of illness, he had significantly elevated IgE levels in
both serum and cerebrospinal fluid. Serologic analysis of antibodies against ganglioside complexes (anti-GDIa, anti-GDIb,
anti-GM1, anti-GM2, anti-GM3, anti-GQIb and anti-GTIb antibodies) showed negative results.
Conclusions: Since asthma has recently been related to autoimmune disease, our case supports an autoimmune
mechanism underlying the clinical spectrum composed of BBE, MFS and GBS. However, contrary to a proposed anti-
GQ1b antibody syndrome, we would suggest that pathogenesis of this clinical spectrum is not limited to anti-
ganglioside antibodies.
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Background
Patients with overlapping Bickerstaff ’s brainstem en-
cephalitis (BBE), Miller Fisher syndrome (MFS) and
Guillain-Barré syndrome (GBS) were rarely reported
outside of Japan. The three disorders have been consid-
ered part of a clinical spectrum, however, a common
underlying pathophysiology is still being investigated [1].
An anti-GQ1b antibody syndrome has been proposed to
associate BBE, MFS, GBS and other similar conditions
[2]. Despite this proposed anti-GQ1b syndrome, a posi-
tive anti-GM1 antibody has also been demonstrated in
an overlapping case of BBE, MFS and GBS rather than
the expected anti-GQ1b [3]. Here, we report a case of
overlapping BBE, MFS and GBS, in which all tested gan-
glion nucleoside antibodies were negative, serum IgE
showed significant elevation, and a positive family his-
tory of bronchial asthma was present. Most recently,
studies have suggested that asthma has an autoimmune
pathogenesis similar to various autoimmune diseases [4].
The patient displayed BBE, MFS and GBS as a continu-
ous clinical course related to an autoimmune response.
Since various autoimmune mechanisms have been sug-
gested for asthma [5] a clinical syndrome composed of
BBE, MFS and GBS may have a broader immunologic
basis rather than a single autoantibody-mediated re-
sponse against a ganglioside complex.
* Correspondence: dailynewsun@yahoo.com
2Department of Neurology, Xuan Wu Hospital of Capital Medical University,
100053 Beijing, People's Republic of China
Full list of author information is available at the end of the article
© 2012 Chongyu et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Han et al. BMC Research Notes 2012, 5:295
http://www.biomedcentral.com/1756-0500/5/295
Case presentation
Case report
A 20-year-old male, suffered from cough, rhinorrhea,
wheezing and dyspnea after exposure to rainy environ-
mental conditions. He was diagnosed with asthma in
childhood. Positive family history of asthma included his
mother and three elder sisters. Following treatment with
inhaled corticosteroids, the symptoms abated over the
next three days. Nine days after the onset of his asthma
exacerbation, he developed an unsteady gait (day 1). The
symptoms persisted, and on day 3 he developed blurred
vision, dizziness, and nausea. On day 12, he became
intermittently drowsy, however, he could be aroused by
noxious stimulation. Six days later (day 18), he experi-
enced an episode of tonic-clonic seizures. This episode
brought him to the attention of the neurological team.
On neurological examination he was fully conscious,
had a wide-based gait, and was unable to stand on one
foot. Limitations of lateral gaze in the left eye and verti-
cal gaze in both eyes were observed. Motor and sensory
functions were intact. Brain computed tomography (CT)
and cerebrospinal fluid (CSF) examination showed no
abnormalities. Electroencephalography (EEG) showed a
4–6 cycle per second slow wave pattern diffusely, and a
22–26 cycle per second waveform predominantly over
centroparietal area, bilaterally (Figure 1). Brainstem en-
cephalitis was tentatively diagnosed, and the patient was
given intravenous dexamethasone (10 mg per day) for
treatment. Despite the treatment, the patient’s symptoms
deteriorated, his level of consciousness varied from occa-
sional drowsiness to lethargy, and on day 21, he devel-
oped quadriplegia. On the Medical Research Council
(MRC) scale, his muscle strength was grade one for all
limbs. Triceps brachii and biceps brachii reflexes were
decreased bilaterally, and brachioradialis reflexes were
absent bilaterally. Patellar and achilles reflexes were also
absent bilaterally. Plantar reflexes were equivocal. CSF
examination showed albuminocytologic dissociation with
64 mg/mL protein and 2/μL cells. Serologic and CSF
screenings for IgM antibodies against cytomegalovirus
(CMV), Herpes Simplex Virus I (HSV-I), Coxsackie virus
(CV), Measles virus (MV), Epstein-Barr virus (EBV), as
well as EBV viral capsid antigen (VCA) IgA were all
negative. Serologic analysis of antibodies against ganglio-
side complexes (anti-GDIa, anti-GDIb, anti-GM1, anti-
GM2, anti-GM3, anti-GQIb and anti-GTIb antibodies)
were negative. Serum and CSF examination, revealed
significantly elevated IgE levels in both the serum
(14.4 mg/L, normal range: 0.1-0.9 mg/L) and CSF
(0.046 mg/L, normal range: undetectable), whereas, IgA,
IgM and IgG were within the normal range. Nerve con-
duction study (NCS) revealed peripheral nerve abnor-
malities characterized by axonal damage (Figure 2). Both
motor conduction velocity and sensory conduction
velocity were normal in the four limbs. Motor nerve
conduction study showed variable decreased amplitude
at the median, ulnar, tibial, and peroneal nerves on both
sides. The right peroneal nerve showed slightly pro-
longed latency. Sensory nerve conduction study
recorded decreased amplitude at the left tibial nerve, but
the right sural nerve, right median nerve and left ulnar
nerve were relatively spared. Left median F-wave could
not be elicited, but H-wave was evoked normally. Over-
all, the NCS findings were consistent with a diagnosis of
GBS with predominant axonal damage.
Results
The patient was diagnosed with BBE and concurrent
MFS and GBS. The patient was in a hypersensitive state
as evidenced by his increased serum and CSF IgE levels
and precipitating asthma symptoms, thus intravenous
dexamethasone (20 mg per day) was used. The dose of
dexamethasone was reduced by half five days later, then
after another five days, switched to oral prednisone and
tapered. The patient improved gradually; by day 37, he
could speak hoarsely and feed himself. His eye move-
ments were sufficient, but demonstrated horizontal nys-
tagmus. Symmetrical limb weakness registered 2–3 in
the arms and 1–2 in the legs on the MRC scale. Deep
tendon reflexes were present, but reduced in all 4 limbs.
A follow-up visit by telephone, on day 132, found the
patient still recovering. His nystagmus and ataxia had
disappeared, the muscle strength of his arms had recov-
ered, he could walk around with support, and the only
problem remaining was bilateral leg weakness.
Conclusions
BBE, MFS and GBS are considered to form a continuous
clinical spectrum with variable central nervous system
(CNS) and peripheral nervous system (PNS) involvement.
Diagnosis of each disorder relies primarily on clinical
presentation and physical examination (Table 1). Accord-
ing to the diagnostic criteria put forward by Odaka et al.
[2], BBE constitutes a clinical entity characterized by acute
ophthalmoplegia, ataxia, disturbance of consciousness or
brisk reflexes. Abnormal lesions on MRI were found in
about 30% of patients, and EEG presented slow-wave ac-
tivity in the θ to δ range indicating involvement of CNS.
Albuminocytological dissociation in the CSF and anti-
GQ1b IgG antibody in serum are frequently detected.
GBS is an acute demyelinating polyneuropathy manifested
as progressive and symmetrical limb weakness for up to
four weeks, accompanied by loss of deep tendon reflexes.
Supportive evidences include relatively mild sensory loss,
cranial neuropathy, and neurophysiological changes in-
volving demyelination or axonal damage in peripheral
nerves and spinal roots [6]. MFS is a rare variant of GBS,
featured by a clinical triad of ophthalmoplegia, ataxia and
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areflexia. Albuminocytological dissociation is present in
most cases of GBS and MFS [7].
Odaka and his colleagues [8] reviewed clinical profiles
and laboratory findings in 62 cases of BBE, and found a
high proportion (37 out of 62, 60%) of patients with con-
current GBS. These GBS syndromes were predominantly
characterized by axonal damage. Some patients had add-
itional MFS, suggesting that the three conditions are
closely related. Our patient initially presented with ataxia
and ophthalmoplegia, and later developed consciousness
disturbances. As the disease progressed, his deep tendon
reflexes reduced to areflexia, and he developed quadri-
plegia. At this time, the CSF began to show albuminocy-
tologic dissociation. Based on the course of illness, the
patient fits a diagnosis of a combined BBE, MFS and
GBS syndrome. An axonal form of GBS revealed by elec-
tromyogram (EMG) in our patient supports the idea that
a considerable number of BBE patients have a concur-
rent axonal Guillain-Barré syndrome [8].
Prior to the occurrence of BBE, our patient had a cough
and rhinorrhea. These symptoms were quickly followed by
wheezing and dyspnea, diagnosed as an episode of bron-
chial asthma. Further examinations of CMV, HSV-I, CV,
MV and EBV in serum and CSF showed negative results,
and serum antibodies against ganglioside complexes were
also negative. Our findings support neither the proposal of
BBE, MFS and GBS as an anti-GQ1b syndrome [2], nor
the idea of an anti-GM1-mediated process for this clinical
spectrum [3]. A special phenomenon associated with our
patient is his past history of bronchial asthma and positive
family history. Twenty-one days after the onset of BBE, his
serum and CSF immunoglobulin showed normal concen-
trations of IgA, IgM and IgG, but significantly elevated
IgE levels. Fifteen-fold increase of serum IgE level in the
patient suggests that the asthma episode precipitated the
combined BBE, MFS and GBS syndrome. In fact, asthma
patients usually have a higher serum IgE level at the re-
mission stage compared with healthy people [9], and IgE
mediated autoallergy has been implicated in various auto-
immune disorders such as rheumatoid arthritis, bullous
pemphigoid and chronic spontaneous urticaria [10-11].
Most recently, Calenoff reported that IgE-mediated mast
cell degranulation was possibly involved in the pathogen-
esis of multiple sclerosis, a well-known CNS autoimmune
disease [12]. The association of asthma with BBE in our
patient was indirectly supported by his response to steroid
treatment.
Recently, an intriguing development in the field of
asthma is its relationship with autoimmune disease.
Asthma had long been considered a classic allergy
eyeopened eyeclosed
Figure 1 Electroencephalography pattern from 20-year-old patient with overlapping Bickerstaff’s brainstem encephalitis, Miller Fisher
syndrome, and Guillain-Barré syndrome. A diffuse slow wave EEG pattern with 4-6 cycles per second is seen in all electrodes. Twenty-two to
twenty-six cycles per second waveform predominates over the centroparietal area, bilaterally. The alpha rhythm over the occipital electrodes was
absent. By the time of examination, the patient’s consciousness level demonstrated intermittent drowsiness, suggesting a diagnosis of
encephalitis.
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1Motor Nerve Conduction:
Nerve & Site Latency Amplitude Segment Latency Distance Velocity
R.laibiT
Ankle 3.6 ms 2.109 mV Abductor hallucis-Ankle 3.6 ms mm m/s
Popliteal 
fossa
11.8 ms 2.812 mV Ankle-Popliteal fossa 8.2 ms 420 mm 51 m/s
R.laenoreP
Ankle 6.0 ms 0.131 mV
Extensor digitorum 
brevis-Ankle
6.0 ms mm m/s
Fibula (head) 12.7 ms 0.163 mV Ankle-Fibula (head) 6.7 ms 280 mm 42 m/s
L.laibiT
Ankle 5.0 ms 0.812 mV Abductor hallucis-Ankle 5.0 ms mm m/s
Popliteal 
fossa
14.5 ms 0.875 mV Ankle-Popliteal fossa 9.5 ms 420 mm 44 m/s
L.laenoreP
Ankle 5.0 ms 0.193 mV
Extensor digitorum 
brevis-Ankle
5.0 ms mm m/s
Fibula (head) 9.4 ms 0.231 mV Ankle-Fibula (head) 4.4 ms 270 mm 61 m/s
R.naideM
Wrist 3.5 ms 0.922 mV Wrist-Elbow 4.6 ms 230 mm 50 m/s
Elbow 8.1 ms 0.943 mV ms mm m/s
R.ranlU
Wrist 2.6 ms 5.247 mV Wrist-Below elbow 4.5 ms 230 mm 51 m/s
Below elbow 7.1 ms 4.844 mV ms mm m/s
L.naideM
Wrist 3.2 ms 0.935 mV Wrist-Elbow 3.7 ms 200 mm 54 m/s
Elbow 6.9 ms 0.312 mV ms mm m/s
L.ranlU
Wrist 3.0 ms 3.885 mV Wrist-Below elbow 3.7 ms 210 mm 57 m/s
Below elbow 6.7 ms 3.948 mV ms mm m/s
F-wave:
Nerve M-Latency F-Latency F-NO. 
Median.L 4.5 0.0 
H-reflex:
Nerve: Median L Latency Amplitude (max) 
M-wave: 4.7 ms mV
H-wave: 31.0 ms mV 
Sensory Nerve Conduction:
Nerve & Site Latency Amplitude Segment Latency Distance Velocity
Sural.R 
Ankle 3.9 ms Lower leg-Ankle 3.9 ms 170 mm 44 m/s
Ankle 4.1 ms Lower leg-Ankle 3.9 ms mm m/s
Tibial.L 
Dorsum of foot 4.1 ms Ankle-Dorsum of foot 4.1 ms 180 mm 44 m/s
Dorsum of foot 4.2 ms Ankle-Dorsum of foot 4.1 ms mm m/s
Median.R 
Digit II (index 
finger) 3.1 ms
Wrist-Digit II (index 
finger) 3.1 ms 170 mm 55 m/s
Digit II (index 
finger) 3.1 ms
Wrist-Digit II (index 
finger) 3.1 ms mm m/s
Ulnar.L 
Wrist 2.6 ms
Digit V (little 
finger)-Wrist 2.6 ms 150 mm 59 m/s
Wrist 2.6 ms
Digit V (little 
finger)-Wrist 2.6 ms mm m/s
Figure 2 Image of nerve conduction study data. Motor nerve conduction study showed normal velocity in the four limbs but variable
decreased amplitude at the median, ulnar, tibial, and peroneal nerves on both sides. The right peroneal nerve showed slightly prolonged latency.
The sensory nerve conduction study was otherwise normal except for the decreased amplitude at the left tibial nerve. Left median F-wave could
not be elicited, but H-wave was evoked normally.
Han et al. BMC Research Notes 2012, 5:295 Page 4 of 6
http://www.biomedcentral.com/1756-0500/5/295
disorder, thought to be mechanistically, distinctly differ-
ent from autoimmune disorders. However, during the
past several years, multiple studies have reported a high
proportion of asthma patients with coexisting auto-
immune diseases: type 1 diabetes, rheumatoid arthritis,
Crohn’s disease and Addison’s disease were most fre-
quently reported [13]. Based on these findings, a com-
mon pathogenetic effector pathway has been suggested,
and mast cells, T cells, and cytokines are all potential
candidates as key regulators of the immune response in
both asthma and autoimmune conditions [4].
An autoimmune mechanism is most probably involved
in the pathogenesis of asthma, and the present case sug-
gests that the clinical spectrum composed of BBE, MFS
and GBS is also associated with an autoimmune mech-
anism [2]. Recently, increased incidence of antinuclear
antibodies and autoantibodies against bronchial epithe-
lial or endothelial antigens have been found in asthma
patients, such as autoantibodies against cytokeratin-18,
alpha-enolase and IgE [14-15]. In addition, common loci
of single nucleotide polymorphisms (SNPs) have been
found to alter the risk for asthma, type 1 diabetes, pri-
mary biliary cirrhosis, and Crohn disease [5]. Therefore,
although serum antibodies against ganglioside com-
plexes were negative in our patient, the possibility exists
that other antibody-mediated autoimmune responses or
SNPs facilitated susceptibility and induced a continuous
morbidity of BBE, MFS and GBS.
Consent
Written informed consent was obtained from the patient
for publication of this Case report and any accompanying
images. A copy of written consent is available for review
by the Editor-in-Chief of this journal.
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